A biotech startup has demonstrated the potential of AI in laboratory settings by allowing an AI agent to select and administer a gene therapy in a live mouse. The experiment involved a custom-built surgical setup where the AI controlled the injection process after selecting from multiple treatment options.
Despite some technical challenges, the AI's ability to perform complex tasks in real-time highlights a significant step towards integrating AI into medical research, potentially enhancing the reliability of experimental outcomes.